Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-23

Clinical Trial Update: Ivabradine for Heart Rate Control In Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ivabradine for heart rate control in septic shock is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVABRADINE

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Septic Shock | Phase 3 | Status: ACTIVE_NOT_RECRUITING